This study first reveals the molecular mechanism by which the (P)RR/ERK/PPARγ pathway participates in the development of hypertension combined with MAFLD, providing support for the development of future therapeutic drugs for hypertension combined with MAFLD. Here, MAPK1 is linked to Hypertension.